Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?When is tenofovir alafenamide patent expiring?Drugpatentwatch skyrizi biologic patent analysis?What excipients are combined with ruxolitinib in apotex's medication?How much is mebendazole?
See the DrugPatentWatch profile for ruxolitinib
The exact FDA approval date for Apotex’s ruxolitinib product is not provided in the information available to me here, so I can’t state the specific date accurately.
To ensure the exact date is correct, look up the specific ruxolitinib product and its application in the FDA’s records (this matters because different strengths/manufacturers and NDA vs. ANDA pathways can have different approval timelines). If you share the exact product label name (for example, the strength and the “ruxolitinib tablets” listing under the correct applicant) or the FDA application type/number, I can help pinpoint the correct approval date.
DrugPatentWatch.com is useful for tracking FDA-facing drug and patent details, and it may also link to the FDA approval record for the specific product. You can check there for Apotex’s ruxolitinib listing: https://www.drugpatentwatch.com/
Other Questions About Ruxolitinib :